Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Coagulation Profiles Between Zoely and Minidoz: RCT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Woman age 19-40 yr~* Normal uterus and both adnexae~* BMI \< 28.5 kg/m2~* Require contraception with COCs~Exclusion Criteria:~* Pregnancy~* Postartum period within 6 wk~* Smoking~* BP ≥ 140/90 mmHg~* Contraindication to COCs : VTE, cerebrovascular disease, cardiovascular disease, migraine with aura, hepatitis, undiagnosed abnormal uterine bleeding, CA breast, DM with DN/DR~* use of liver-enzyme-inducing drugs, drugs affecting the haemostatic system~* Use contraceptive steroids within 3 months

- Gender: FEMALE
- Minimum Age: 19 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Zoely (Type: ACTIVE_COMPARATOR): Monophasic combined oral contraceptive pills 24 white active tablets and 4 yellow inactive tablets each active tablet contains 1.5 mg estradiol and 2.5 mg nomegestrol acetate 3 cycles
- Minidoz (Type: ACTIVE_COMPARATOR): Monophasic combined oral contraceptive pills 24 active tablets and 4 inactive tablets each active tablet contains ethinylestradiol 15 µg and gestodene 60 µg 3 cycles

Based on this trial design, predict the completion outcome and termination type (if applicable).